PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Announces FDA Approval for Sogroya

Novo Nordisk A/S has announced that its drug Sogroya received FDA approval for three new indications.

1 Mar, 09:27 — 1 Mar, 09:27
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual38d ago

Novo Nordisk A/S (NVO) Announces FDA Approval of Three New Indications for Sogroya

Read full article →

Related Stories

Manila Water prepares for summer heat and high demand

just now

Ozempic Patent Expiration Leads to Flood of Generics and Abuse Concerns in Asia

19m ago

Measles Outbreak Spreads from Rural to Urban Utah

31m ago

Philippines Announces Results of April 2026 Physicians Licensure Examination

34m ago